UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Vigilare Wealth Management

Vigilare Wealth Management trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 1.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,352 shares of the healthcare conglomerate’s stock after selling 29 shares during the period. UnitedHealth Group accounts for about 0.7% of Vigilare Wealth Management’s holdings, making the stock its 25th biggest holding. Vigilare Wealth Management’s holdings in UnitedHealth Group were worth $1,247,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Axiom Financial Strategies LLC acquired a new stake in UnitedHealth Group during the first quarter worth about $210,000. McGowan Group Asset Management Inc. increased its position in UnitedHealth Group by 8.9% during the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after purchasing an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in UnitedHealth Group by 31.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after purchasing an additional 60,300 shares during the last quarter. MAS Advisors LLC increased its position in UnitedHealth Group by 10.8% during the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after purchasing an additional 45 shares during the last quarter. Finally, First Western Trust Bank acquired a new stake in UnitedHealth Group during the first quarter worth about $875,000. 86.31% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent analyst reports. Morgan Stanley reiterated an “overweight” rating and set a $587.00 price target on shares of UnitedHealth Group in a research report on Wednesday, November 23rd. Stephens reiterated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research report on Tuesday, February 28th. UBS Group dropped their price target on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating for the company in a research report on Wednesday, January 18th. Credit Suisse Group lifted their price target on shares of UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, December 7th. Finally, Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price objective for the company. in a research note on Monday, November 21st. Three research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $599.68.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $469.50 on Friday. The firm has a market capitalization of $437.97 billion, a PE ratio of 22.16, a price-to-earnings-growth ratio of 1.30 and a beta of 0.69. The business’s fifty day moving average price is $483.26 and its 200 day moving average price is $510.78. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a 12 month low of $449.70 and a 12 month high of $558.10.

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, beating the consensus estimate of $5.17 by $0.17. The firm had revenue of $82.79 billion for the quarter, compared to analyst estimates of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. UnitedHealth Group’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.48 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 24.91 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 21st. Shareholders of record on Monday, March 13th will be issued a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Friday, March 10th. UnitedHealth Group’s payout ratio is 31.15%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.